Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS
Restricted accessOtherFirst published online September, 2009
Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS
Cognitive impairment is common in multiple sclerosis (MS) affecting roughly 45–60% of patients. Because memory deficits have significant impact on employment, caregiver burden, and social functioning, neuropsychological (NP) assessment is often recommended. Two widely used and validated NP batteries for MS are the Rao Brief Repeatable Neuropsychological Battery (BRNB) and the Minimal Assessment of Cognitive Function in MS (MACFIMS). Although similar, these batteries differ in the specific auditory/verbal and visual/spatial memory tests employed. The relative sensitivity of these memory tests is unknown.
Methods
The BRNB and MACFIMS have considerable overlap but different memory tests: the former includes the Selective Reminding Test (SRT) and the 10/36 Spatial Recall Test (10/36) and the latter the California Verbal Learning Test, Second Edition (CVLT2) and Brief Visuospatial Memory Test, Revised (BVMTR). In 65 patients with MS and 46 demographically matched controls, we compared the sensitivity of these tests, and secondarily their respective batteries.
Results
The BRNB and MACFIMS were comparable in their overall sensitivity to disease status. Although the BVMTR showed greater discriminative validity than the 10/36, the CVLT2 and SRT were comparable in sensitivity. The SDMT was the most sensitive NP test across both batteries.
Conclusions
We conclude that the BRNB and MACFIMS have comparable sensitivity among patients with MS. The sensitivity of the auditory/verbal memory tests from these batteries is similar, but the BVMTR appears to be more sensitive than the 10/36. Clinical implications are discussed.
1 Rao SM Leo GJ Bernardin L Unverzagt F . Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology1991; 41: 685–691.
2.
2 Benedict RHB Cookfair D Gavett R . Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc2006; 12: 549–558.
3.
3 Achiron A Barak Y . Cognitive changes in early MS: a call for a common framework. J Neurol Sci2006; 245: 47–51.
4.
4 Deloire MS Bonnet MC Salort E . How to detect cognitive dysfunction at early stages of multiple sclerosis. Mult Scler2006; 12: 445–452.
5.
5 Rao SM Leo GJ Ellington L Nauertz T Bernardin L Unveragt F . Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology1991; 41: 692–696.
6.
6 Beatty WW Blanco CR Wilbanks SL Paul RH . Demographic, clinical, and cognitive characteristics of multiple sclerosis patients who continue to work. J Neurol Rehabil1995; 9: 167–173.
7.
7 Benedict RHB Wahlig E Bakshi R . Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci2005; 231: 29–34.
8.
8 Benedict RHB . Integrating cognitive function screening and assessment into the routine care of multiple sclerosis patients. CNS Spectr2005; 10: 384–393.
9.
9 Benedict RHB . Effects of using same vs. alternate form memory tests in short-interval, repeated assessment in multiple sclerosis. J Int Neuropsychol Soc2005; 11: 727–736.
10.
10 Bobholz JA Rao SM . Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol2003; 16: 283–288.
11.
11 Buschke F Fuld PA . Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology1974; 24: 1019–1025.
12.
12 Barbizet J Cany E . Coinical and psychometric study of a paitent with memory disturbances. Int J Neurol1968; 7: 44–54.
13.
13 Borkowski JG Benton AL Spreen O . Word fluency and brain damage. Neuropsychologia1967; 5: 135–140.
14.
14 Gronwall DMA . Paced auditory serial addition task: a measure of recovery from concussion. Percept Mot Skills1977; 44: 367–373.
15.
15 Rao SM; . A Manual for the brief, repeatable battery of neuropsychological tests in multiple sclerosis 1991 (unpublished paper).
16.
16 Smith A . Symbol digit modalities test: manual.Los Angeles: Western Psychological Services; 1982.
17.
17 Christodoulou C Krupp LB Liang Z . Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology2003; 60: 1793–1798.
18.
18 Amato MP Bartolozzi ML Zipoli V . Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology2004; 63: 89–93.
19.
19 Amato MP Ponziani G Siracusa G Sorbi S . Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol2001; 58: 1602–1606.
20.
20 Amato MP Ponziani G Pracucci G Bracco L Siracusa G Amaducci L . Cognitive impairment in early-onset multiple sclerosis: pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol1995; 52: 168–172.
21.
21 Huijbregts SC Kalkers NF de Sonneville LM de Groot V Polman CH . Cognitive impairment and decline in different MS subtypes. J Neurol Sci2006; 245: 187–194.
22.
22 Camp SJ Stevenson VL Thompson AJ . A longitudinal study of cognition in primary progressive multiple sclerosis. Brain2005; 128: 2891–2898.
23.
23 Sepulcre J Vanotti S Hernandez R . Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test. Mult Scler2006; 12: 187–195.
24.
24 Benedict RHB Fischer JS Archibald CJ . Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol2002; 16: 381–397.
25.
25 Benedict RHB . Brief visuospatial memory test - revised: professional manual.Odessa, Florida: Psychological Assessment Resources, Inc; 1997.
26.
26 Benedict RHB Schretlen D Groninger L Dobraski M Shpritz B . Revision of the Brief Visuospatial Memory Test: Studies of normal performance, reliability, and validity. Psychol Assess1996; 8: 145–153.
27.
27 Benedict RHB Zgaljardic DJ . Practice effects during repeated administrations of memory tests with and without alternate forms. J Clin Exp Neuropsychol1998; 20: 339–352.
28.
28 Delis DC Kramer JH Kaplan E Ober BA . California verbal learning test manual.2nd ed.San Antonio, TX: Psychological Corporation; 2000 [Adult Version].
29.
29 Benedict RHB Groninger L . Preliminary standardization and validation of a new visuospatial memory test with six alternate forms. Clin Neuropsychol1995; 9: 11–16.
30.
30 Delis DC Kaplan E Kramer JH . Delis-Kaplan executive function system.San Antonio, Texas: Psychological Corporation; 2001.
31.
31 Benton AL Sivan AB Hamsher K Varney NR Spreen O . Contributions to neuropsychological assessment.2nd ed.New York: Oxford University Press; 1994.
32.
32 Polman CH Reingold SC Edan G . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol2005; 58: 840–846.
33.
33 Duquin JA Parmenter BA Benedict RHB . Influence of recruitment and participation bias on neuropsychological research among MS patients. J Int Neuropsychol Soc2008; 14: 494–498.
34.
34 APA. Diagnostic and statistical manual of mental disorders.4th ed.Washington DC: American Psychiatric Association; 2000 [Text Revision].
35.
35 Lublin FD Reingold SC . Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology1996; 46: 907–911 [see comment].
36.
36 Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Ann Neurol1983; 13: 227–231.
38 Beck AT Steer RA Brown GK . BDI-Fast screen for medical patients: manual.San Antonio, TX: Psychological Corporation; 2000.
39.
39 Benedict RHB Fishman I McClellan MM Bakshi R Weinstock-Guttman B . Validity of the Beck Depression Inventory - Fast Screen in multiple sclerosis. Mult Scler2003; 9: 393–396.
40.
40 Rudick RA Cutter G Baier M . Use of the multiple sclerosis functional composite to predict disability in relapsing MS. Neurology2001; 56: 1324–1330.
41.
41 DeLuca J Barbieri-Berger S Johnson SK . The nature of memory impairments in multiple sclerosis: Aquisition versus retrieval. J Clin Exp Neuropsychol1994; 16: 183–189.
42.
42 Denney DR Lynch SG Parmenter BA . A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters. J Neurol Sci2008; 267: 129–136.
43.
43 Boringa JB Lazeron RH Reuling IE . The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice. Mult Scler2001; 7: 263–267.
44.
44 Benedict RHB Bruce JM Dwyer MG . Neocortical atrophy, third ventricular width, and cognitive dysfunciton in multiple sclerosis. Arch Neurol2006; 63: 1301–1306.
45.
45 Gontkovsky ST Vickery CD Beatty WW . Construct validity of the 7/24 Spatial Recall Test. Appl Neuropsychol2004; 11: 75–84.
46.
46 Cutter GR Baier ML Rudick RA . Development of a multiple sclerosis funcitonal composite as a clinical trial outcome measure. Brain1999; 122: 871–882.
47.
47 Fischer JS Rudick RA Cutter GR Reingold SC . The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler1999; 5: 244–250.
48.
48 Rudick RA Goodkin DE Jacobs LD . Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology1997; 49: 358–363.
49.
49 Benedict RHB Weinstock-Guttman B Fishman I Sharma J Tjoa CW Bakshi R . Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol2004; 61: 226–230.
50.
50 Tekok-Kilic A Benedict RHB Weinstock-Guttman B . Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. Neuroimage2007; 36: 1294–1300.
51.
51 Houtchens MK Benedict RHB Killiany R . Thalamic atrophy and cognition in multiple sclerosis. Neurology2007; 69: 113–123.
52.
52 Parmenter BA Weinstock-Guttman B Garg N Munschauer F Benedict RHB . Screening for cognitive impairment in MS using the Symbol Digit Modalities Test. Mult Scler2006; 13: 52–57.
